BEIZRAY
Docetaxel
- Strength
- 20 mg/mL
- Form
- Injection, Solution
- Class
- Microtubule Inhibitor
Zhuhai Beihai Biotech Co., Ltd.
Not stocked by us — reference only
Listed by Mylan Institutional LLC
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Microtubule Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 67457-781 |
| FDA application | ANDA208137 |
| RxNorm concept | 1001405 |
| Package sizes listed | 1 |
| Marketed since | June 2019 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Docetaxel
Zhuhai Beihai Biotech Co., Ltd.
Not stocked by us — reference only
Docetaxel
Zhuhai Beihai Biotech Co., Ltd.
Not stocked by us — reference only
Docetaxel
Zydus Pharmaceuticals USA Inc.
Not stocked by us — reference only
Docetaxel
Zydus Pharmaceuticals USA Inc.
Not stocked by us — reference only
Sun Pharmaceutical Industries, Inc.
Not stocked by us — reference only
Amneal Pharmaceuticals LLC
Not stocked by us — reference only
Meitheal Pharmaceuticals Inc.
Not stocked by us — reference only
DOCETAXEL ANHYDROUS
Hospira, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.